MBOT Stock Microbot Medical (MBOT, $3.09) entered a monthly bullish trend. Expect an Uptrend continuation

GET DAILY SIGNALS

Get AI intraday signals

MBOT - Microbot Medical

Bullish Trend Signal

View

Odds of UP Trend

Loading...

Price: $3.09

Daily change: +$0.17 (+5.82%)

Daily volume: 1.9M

Capitalization: $130M

Industry: Pharmaceuticals: Other

MBOT sees its Stochastic Oscillator ascending out of oversold territory

On August 05, 2025, the Stochastic Oscillator for MBOT moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 67 instances where the indicator left the oversold zone. In of the 67 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 01, 2025. You may want to consider a long position or call options on MBOT as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MBOT just turned positive on August 05, 2025. Looking at past instances where MBOT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

MBOT moved above its 50-day moving average on August 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MBOT crossed bullishly above the 50-day moving average on July 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MBOT advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 113 cases where MBOT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MBOT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MBOT broke above its upper Bollinger Band on August 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MBOT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.490) is normal, around the industry mean (10.661). P/E Ratio (0.000) is within average values for comparable stocks, (62.050). MBOT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.847). MBOT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.000) is also within normal values, averaging (83.916).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBOT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.